chrisvoncsefalvay/vaers-outcomes huggingface dataset:
expired Moderna vaccine administered past 12 hours puncture time; expired Moderna vaccine administered past 12 hours puncture time; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered past 12 hours puncture time) and PRODUCT STORAGE ERROR (expired Moderna vaccine administered past 12 hours puncture time) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered past 12 hours puncture time). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (expired Moderna vaccine administered past 12 hours puncture time). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired Moderna vaccine administered past 12 hours puncture time) and PRODUCT STORAGE ERROR (expired Moderna vaccine administered past 12 hours puncture time) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was provided. Patient received 2nd booster dose. Date the vial was initially stored in the refrigerator was reported as 4-APR-2022 Date(s) and time(S) vial was first punctured reported as 4-APR-2022 at 1:55 PM Date(s) and time(s) of administration of vaccine was 5-APR-2022 at 9:00 AM - 1:40 PM The vial was stored in Refrigerator after post puncture. It was reported that the vial doesn't undergone any temperature excursions and total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) was Unknown. it was reported that not more than 24hours the vial was exposed. No treatment information was provided.
Patient developed bilateral upper extremity papular rash s/p receiving hepatitis B vaccine to (L) arm & influenza vaccine to (R) arm. No other symptoms.
1 by 1 cm redden area to (R) thigh & Rash noted to stomach + legs -, mom stated started with rash to site the next am and rash started 12/19/08.
Dizziness; nausea; itchy red arm/full body itch; itchy red arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Mar2021 09:00 (Lot number: EP6955) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Yes, many " (unspecified if ongoing). Concomitant medication(s) included: SINGULAIR; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; CLARITINE; BENADRYL; PREVACID. The following information was reported: DIZZINESS (non-serious) with onset 22Mar2021, outcome "recovering", described as "Dizziness"; NAUSEA (non-serious) with onset 22Mar2021, outcome "recovering", described as "nausea"; PRURITUS (non-serious) with onset 22Mar2021, outcome "recovering", described as "full body itch"; PRURITUS (non-serious), ERYTHEMA (non-serious) all with onset 22Mar2021, outcome "recovering" and all described as "itchy red arm". Therapeutic measures were not taken as a result of dizziness, nausea, pruritus, pruritus, erythema.  Additional information: It was reported that prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, she has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other vaccines within 4 weeks prior to the COVID vaccine.   No follow-up attempts are possible. No further information is expected.
Within a few days of the varicella vaccine, she developed what appeared to be chicken pox on her body and especially around the area where the vaccine dose was given. We went back to the dr on 5-6-09 and he said she had chicken pox, to not be near anyone else's babies that hadn't had the vaccines, or pregnant women, etc, and to cover the area and essentially quarantine ourselves until it had run it's course. He said she was not to have any more of this particular vaccine.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. No medical history was reported. On 13-JUN-2013, the patient was vaccinated with an expired dose of GARDASIL (lot # 668670/0476AA, expiry: 03-JUN-2013) 0.5 ml, intramuscularly. No concomitant medications were reported. No adverse effect reported. This is one of 2 reports received from the same reporter. Additional information has been requested.
Right occiput felt numb and stayed that was. Ten days later the numbness radiated around to right eyebrow. Currently the same but no further progression. Hands and feet feel "weird", diminished sensation as one would feel when one's foot falls asleep. Intermittent headache primary right sided; dull and throbbing. She has occasionally taken Advil which somewhat relieves it. No vision or cognitive changes. One time she had liquid stool incontinence with no warning. Had two instances in which right foot came out from under her while on treadmill and regained balance. She has not seen her physician for this matter. 11/30/09 Neurology consult records received for DOS 11/12/09. Pt. presents with numbness of the skull, feet and hands on the right.  DX: post vaccination induced sensory mononeuritis multiplex, sensory variant of Guillain-Barre syndrome 11/30/09 PCP records received for DOS 11/11/09.  Pt presented numbness of back of head and tips of fingers .  Reported that numbness moving to hands and feet over past 10 days.
Trouble staying asleep having very strange vivid dreams; Trouble staying asleep having very strange vivid dreams; This is a spontaneous report from contactable consumer, the patient. A 33-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on the right arm on 31Jul2021 at 15:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Aug2021 at 00:00, the patient had trouble staying asleep and had very strange vivid dreams. The patient was typically a sound sleeper and could not recall about the dreams or details when woke up the following morning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events trouble staying asleep and had very strange vivid dreams were recovering at the time of this report.   The lot number for BNT162b2, were not provided and will be requested during follow up.
migraine; I'm sore all over; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of MIGRAINE (migraine) and MYALGIA (I'm sore all over) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced MIGRAINE (migraine) and MYALGIA (I'm sore all over). At the time of the report, MIGRAINE (migraine) and MYALGIA (I'm sore all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. No treatment was reported.
eye inflammation; dry eyes; dim vision; the way I see colors is different; my vision at night is terrible; This is a spontaneous report from a contactable consumer received from marketing program Epsilon.    A  patient of an unspecified gender and age reported that received first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), on unknown date at single dose for COVID-19 immunization. Medical history and concomitant drugs were unknown.  The patient has developed eye problems one week after she took the first shot of Pfizer vaccine. The patient has had eye inflammation and dry eyes and now dim vision and the way the patient sees colors was different. The patient went to three different eye doctors and they don't know why she was having these issues. The patient's  vision at night is terrible and colors seem darker. The outcome of the events was unknown.  Information about lot/batch number has been requested.
1/7/21 - developed widespread tooth sensitivity to hot and cold food 1/11/21 - woke up in the middle of the night with severe tooth and jaw pain on the lower right side 1/12/21 and 1/13/21 - pain spread to include upper and lower jaw/teeth on the right side of my mouth 1/14/21 and 1/15/21 - pain resolved in right lower jaw, pain still present in right upper jaw 1/16/21 - pain isolated to upper right jaw and last molar, could not eat without pain 1/17/21 and 1/18/21 - pain still present but mostly resolved, hot and cold sensitivity recurred  During this timeframe, pain was managed with acetaminophen 1000mg and ibuprofen 800mg as needed
Patient reports dizziness, hot/flushed, and ears ringing;  Patient placed supine x 15 minutes and provided water as requested.  BP 128/72  HR 76  O2 sat 100%    Patient denies any symptoms after 10 minutes. Observed sitting for another 15 minutes
Per the clinical lead Hepatitis B vaccine transported to clinic in Brown portable cooler. A vaccine excursion occurred with the brown portable cooler. The temperature on the brown portable cooler went out of range based on Engerix- B manufacturer recommendations. The portable cooler reconditioned and Hepatitis B vaccine administered to patient. Manufacturer contacted by representative. Per the local Health Department Bureau of Immunization they were advised by GlaxoSmithKline that the Hepatitis B vaccine was not viable and the patient needed to be revaccinated.
beginning 2 days post injection, burning in left forearm, intermittent numbness left hand. 4 days post injection, paresthesia throughout body, limbs, also, widespread muscular twitching.  9 days post-injection, rapid hear rate  when at rest. using oximeter to monitor heart rate throughout day.  general feeling of restlessness  at 10 days post vaccination,  all symptoms persist
10 days p/vax pt had rash w/vesicles by description;seen by MD 12 days p/vax;had vesicular papular rash w/several target lesions;given atarax for itching;
This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient. A 44-year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm left, administration date 04Jun2021 (Lot number: EW0150) at the age of 44 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: Penicillin. The patient did not receive any concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: EW0150, Anatomical location: Left arm, Route of administration: Unspecified), administration date: 14May2021, for COVID-19 immunisation. The following information was reported: DIARRHOEA (non-serious) with onset 05Jul2021, outcome "recovered" (an unknown date in 2021), described as "After receiving first two doses of vaccine, experienced diarrhea for 4 straight weeks"; MIGRAINE (non-serious) with onset 05Jul2021, outcome "not recovered", described as "I have had migraines every day since vaccination. I have to take daily migraine medication"; GENITAL HERPES (non-serious) with onset 05Jul2021, outcome "not recovered", described as "I had an unexplained case of genital herpes."; WEIGHT DECREASED (non-serious) with onset 05Jul2021, outcome "not recovered", described as "I lost 40 pounds"; MALAISE (non-serious) with onset 05Jul2021, outcome "not recovered", described as "I have not felt good since vaccination". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of diarrhoea, migraine, genital herpes, weight decreased and malaise. Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient reported that she now had to take a daily medication to prevent herpes outbreaks. The patient stated that She and her husband were faithful and have had been for 18 years. She had no other way to explain genital herpes. The patient received unspecified medication for the reported events. Since the vaccination, the patient had been tested for COVID-19 and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. The patient also received (BNT162B2), administered in left arm, administration date 10Dec2021 (Lot number: FE3594) at the age of 45 years as dose 3 (booster), single for COVID-19 immunisation.
My muscles were stiff the next day. On 12/24/2020, while playing tennis, I completely tore my achilles.
This spontaneous report was received from a certified medical assistant (also reported as healthcare worker) referring to an adult patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 02-SEP-2015, the patient was vaccinated with a single first dose of pediatric formulation of RECOMBIVAX HB 5 mcg/0.5 ml, lot # J012567 with expiry date of 30-JAN-2016, intramuscular. The reporter stated that "it was outside the labeled recommendations in the RECOMBIVAX HB prescribing information". Concomitant medications were not reported. No adverse effect was reported. There was no product quality complaint involved. Follow up information has been received on 23-DEC-2015 from the healthcare worker who was requesting that no further correspondence follow up Adverse Event information was sent to her as she had no further information to provide. Additional information is not expected.
Feeling bad for 2 weeks; Initial information received on 13-Oct-2020 regarding an unsolicited valid non-serious case received from consumer (patient) via social media.  This case involves a patient of unknown age who had been feeling bad for 2 weeks (feeling abnormal), while received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was feeling bad (feeling abnormal) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, event outcome was unknown.  There will be no information available on batch number for this case.
Received Moderna Bivalent Vaccine (Covid Vax #5 for me), on Friday, September 9.  On Sunday, September 11, I I experienced a large red spot on my arm, located below the injection site which lasted up to 4 days until it started to fade.    From Sunday, September 11 to Friday September 16,  I experienced unexplained dizziness, light-headed feeling and fatigue to which I was unable to work.
pt recv vax 11MAR96 & 19MAR96 pt was lethargic & that same day t104,sz,dots on stomach & back & vomiting;pt was hosp;
t103, rt thigh reddened w/edema devel ear et throat infect et dehydrated; temp & reddness w/edema lasting 2 days;
Pain at injection site then by late afternoon/ early evening my entire left arm was achy and I was tired. By morning my neck and shoulders were achy as well as my left arm and I was still a little fatigued. By the next day my only symptom was soreness in my upper arm and especially at the injection site.  5 days after the injection I still have soreness at the injection site. I took a few doses of tylenol and rested. My job  has forced a 10 day isolation on me because they said fatigue and achy muscles are signs of COVID-19. So I am getting plenty of rest.
Patient stated that she had pain right after the vaccine done.  pain got worse when she got home from her neck down to her hands and not much better after 2 days
I contracted COVID-19 4/10/2022 with symptoms of cough, fever, severe headache, chest congestion, ear infections in both ear, chest pain/tightness, shortness of breathe, lost sense of taste and smell, fatigue, myalgia, chills, nausea, and I was ill for 18 days before the symptoms began to resolve. I have lingering symptoms of cough, headache, and sense of taste and smell are still muted but are returning.
couldn't movelower extremities. Some weakness inarms; No involvement with breathing; This is a spontaneous report from a contactable/non-contactable None[C.2.r.4 (Reporter Type)].  A 82[D.2.2a; age]-Year(s)[ D.2.2b; age unit]-old Male[D.5; gender] patient received BNT162B2[G.k.2.2; suspect product(s) generic name(s) BNT162B2[G.k.2.3.r.1] 1[dose number FDA.G.k.4.r.13] dose:,None[ G.k.4.r.1a; G.k.4.r.1b], None[route(s) of administration or unspecified route G.k.4.r.10.1], administered in Arm Left[add the anatomical location G.k.4.r.11.x1] on 202103171430[G.k.4.r.4; start dates or unspecified date; and time if provided], ER8727[G.k.4.r.7 batch/lot number [Lot #], Expiration date [EXPIRATIONDATE Expiration Date or indicate if they were not reported], [for vaccine indicate the following information] at the age of vaccination 82[FDA.D.2.1a]; as dose(s) with unit] single[DRUGDOSEFREQUENCY], for Covid-19 immunisation[G.k.7.r.1;  indication(s). Medical history included [any information regarding past medical history, concurrent conditions, social history, and family history].   Concomitant medication(s) included Suspect[G.k.1 with value of 2: all concomitant medication names] taken for [indication(s) (if provided)] from [start dates] to [stop dates]. The patient previously took [D.8.r.1; past product] for [indication] and experienced [past event]. The patient experienced couldn't move lower extremities. Some weakness in arms,No involvement with breathing[E.i.1.2; AE(s)] and [indicate the appropriate seriousness criterion at the appropriate point in the description] on 202103171630[E.i.4; AE(s) onset date(s)]. The patient underwent lab tests and procedures, which included [F.r.1 ;any information regarding laboratory tests and procedures]. [He/She] was diagnosed as having [provisional/differential/definitive diagnoses]. The [non-vaccine suspect product(s) only do not add this statement for vaccines products] was/were [action taken] on[date of temporary interruption/withdrawn to be included if applicable]. Therapeutic measures were taken as a result of [AE] and included treatment with [treatment product(s)] from [start date(s) of treatment product(s)] to [stop date(s) of treatment product(s)]. The patient recovering/resolving[E.i.7: outcome(s) of the event(s)]/died] on [E.i.5; AE(s) stop date(s)].
FEW DAYS FOLLOWING THIRD DOSE OF MODERNA VACCINE, PATIENT DEVELOPED HIVES WITH PAIN. MOTHER IS REPORTING ADVERSE EVENT TO US TODAY, AND HIVES HAVE NOT FULLY RESOLVED.
it hurts; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient got the shingle shot and it hurt but it was worth it.
Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 IMMUNISATION (Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 21-May-2021, the patient experienced COVID-19 IMMUNISATION (Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose). At the time of the report, COVID-19 IMMUNISATION (Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication and treatment information was provided. Action taken with mRNA-123 is not applicable.
pt recv word that pt had died on 20MAR97;pt had been sent to ER for fever of 103 approx;
Got injections at 3 PM around 7 PM noticed (R) lymph node sore & swollen then rash occurred on (R) buttocks, red, raised & itchy.
Patient had her vaccine, traveled with her husband for an appointment that was 220+ miles from home and arm started to ache as she sat at husbands appointment. Throughout the day she said her arm got worse and she was unable to use it, also developed fever and chills. Next day chills were better but arm continued to ache, 2 days later arm was more functional, today on day # 3 she is able to lift arm and use it some, no further chills or fever since first day.
My wrist was so painful I couldn't hold anything and I had a headache. I woke up with a headache and my wrist was hurting so bad. I called the doctor that following day. I took Tylenol that day every four hours. I did not actually go to the doctor because my insurance has lapsed. I called lifeline.  My wrist is still very painful.
ABRUPT ONSET OF NAUSEA, CHILLS, ACHINESS, AND EXTREME FATIGUE, WITHIN SEVERAL HOURS HAD FEVER OF 102, VOMITING. DURING NIGHT HAD 2 EPISODES OF SYNCOPE, IN OFFICE NEXT DAY FEVER GONE, BUT BP 82/50; LATER DEVELOPED REDNESS AND SWELLING IN LYMPHEDEMA AFFECTED LEG-TREATED FOR CELLULITIS W KEFLEX